THAR
THAR
NASDAQ · Biotechnology

Tharimmune Inc

$4.14
+0.21 (+5.34%)
As of Feb 8, 2:07 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 184.51M 172.01M 149.83M
Net Income 6.70M 5.27M 5.04M
EPS
Profit Margin 3.6% 3.1% 3.4%
Rev Growth +0.4% +18.6% +9.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 14.44M 14.55M 15.63M
Total Equity 90.07M 76.95M 84.70M
D/E Ratio 0.16 0.19 0.18
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 12.90M 10.88M 9.08M
Free Cash Flow 3.45M 3.47M 2.49M